Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler for the Occurrence of an Acute Ischemic Stroke or Left Ventricular Thrombus in STEMI Patients With Left Ventricular Dysfunction
NCT07932080, Not applicable, Not yet recruiting, CHC Montlegia
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler for the Occurrence of an Acute Ischemic Stroke or Left Ventricular Thrombus in STEMI Patients With Left Ventricular Dysfunction | ClinicalTrials.gov |
| NCT number | NCT07932080 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 116 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | CHC Montlegia | ClinicalTrials.gov |
| Conditions | STEMI, Left Ventricular Thrombus, Acute Ischemic Stroke | ClinicalTrials.gov |
| Interventions | Transcranial doppler (TCD) | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Demonstration of a correlation between the number of MES detected and the 2-year risk of AIS or the occurrence of a LVT at 6 weeks in patients with post-STEMI LVD. | To the enrollment period to 2-years of AIS or 6-weeks of a LVT | ClinicalTrials.gov | |
| Secondary | Demonstration of a correlation between the number of MES detected and the treatment given (single anti-aggregation, double anti-aggregation, anti-coagulation) in patients suffering from LVD | To the enrollment period to 2-years of AIS or 6-weeks of a LVT | ClinicalTrials.gov | |
| Secondary | Demonstration of a correlation between the variation in the number of MES detected and the modification of the treatment administered (single anti-aggregation, double anti-aggregation, anti-coagulation) in patients suffering from LVD | To the enrollment period to 2-years of AIS or 6-weeks of a LVT | ClinicalTrials.gov | |
| Secondary | Demonstration of a correlation between the number of MES and the LVD rate according to the ACCF/AHA Heart Failure classification | At screening | ClinicalTrials.gov | |
| Secondary | Demonstration of a correlation between the number of MES detected and the risk of occurrence of an AIS at 2 years or LVT at 6 weeks in patients suffering from LVD, classified by subgroup of cardiac decompensation according to the ACCF/AHA Heart Failur | To the enrollment period to 2-years of AIS or 6-weeks of a LVT | ClinicalTrials.gov | |
| Secondary | Creation of a large multicentric prospective follow-up database of patients suffering from LVD, whether symptomatic or not | To the enrollment period to the end of the follow-up, three years after | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)